PD-1 jointly developed by Yuheng pharmaceutical and Yaoming biology was approved for listing
Financial Associated Press, August 30 - on August 30, the official website of the State Food and drug administration showed that the anti-PD-1 whole person innovative antibody drug cyprimab (gls-010) jointly developed by Yuheng pharmaceutical / Yaoming biology has been approved by nmpa to be listed for the treatment of patients with recurrent or refractory classic Hodgkin's lymphoma (R / R CHL) above the second line. This is the sixth domestic PD-1 mAb approved by nmpa.
This text is a result of machine translation.
Related companies：
Briefing Mar 13, 2022 08:49 PM
· Financials
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
In-depth
Financials, Healthcare
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Briefing Feb 08, 2022 03:30 PM
· Healthcare
Yaoming biological was included in the "unverified list" in the United States, and its share price plummeted
Healthcare
Stem-cell Firm Hemacell Completes Pre-Series A+ Funding Round
Platelets play a crucial role in the coagulation process in vivo. However, platelets used in clinical practice mainly come from free donations and are in extreme shortage. Using stem cells to produce platelets in vitro is expected to solve this unmet clinical need.
May 27, 2022 04:55 PM
Briefing Feb 07, 2022 08:09 AM
· Healthcare
The battery plant jointly built by SK innovation and Ford was started in December last year
Technology, Healthcare
Healthcare Content Provider VanMul Receives Angle Round Funding
VanMul Health, a Chinese healthcare social media content provider, has received CNY 5 million in angel round funding. The company which founded less than a year ago, is taking a different approach to healthcare content on social media, forming deep partnerships with companies such as Douyin, Tencent, Roche, and Merck & Co.
May 27, 2022 01:50 PM
See more
Read next
In-depth
In-depth
In-depth
Technology
Going Beyond Flat: Kandao QooCam EGO Transcends 'Metaverse' into the Real World
May 25, 2022 02:28 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.